Genpharmasec Ltd.
Fundamentals
- Market cap
- ₹61.46 cr
- P/E
- 38.41×
- ROE
- 1.92%
- Debt / equity
- 0.05
- 52-week range
- 0.75 — 2.20
Company snapshot
Genpharmasec Ltd.
Chemicals
₹68 cr
P/E 42.14×
Latest quarter · Mar 2026
Sales₹55 cr
Net profit₹1 cr
Op. margin+3.6%
EPS₹0.02
Strength & growth
Debt / equity0.05×
Current ratio2.78×
Sales CAGR+108.8%
EPS CAGR+18.6%
The timeline — 2 notes on Genpharmasec Ltd.
May 2026
- 21 May 26 · 5:36 PM IST Brief Brief · Earnings · Micro cap
Genpharmasec revenue surges 4x, consolidated profit slips to ₹56.01 lakh
Standalone revenue jumped to ₹13,134.94 lakh from ₹3,296.07 lakh, but two loss-making subsidiaries dragged consolidated profit to just ₹56.01 lakh, with auditor flagging going-concern uncertainties.
- 21 May 26 · 5:28 PM IST Brief Brief · Earnings · Micro cap
Genpharmasec revenue quadruples but two subsidiaries bleed
Standalone sales hit ₹131 cr, aided by the Derren Healthcare acquisition. Auditor flags going concern doubts on two units despite parent's support.